Literature DB >> 9371488

Dissociation between steroid receptor expression and cell proliferation in the human breast.

R B Clarke1, A Howell, C S Potten, E Anderson.   

Abstract

We have shown previously that estradiol stimulates cell proliferation and progesterone receptor (PgR) synthesis in luminal epithelial cells of the normal human breast. Approximately 10-15% of luminal epithelial cells within the normal breast express immunodetectable estrogen receptor (ER), but little is known about their distribution within lobules and their organization in relation to the smaller population of proliferating cells. Using normal human breast tissue, we show that ER-positive cells are distributed evenly throughout the mammary epithelium. Using double antibody immunofluorescence, we show that 96% of steroid receptor-positive cells synthesize both ER and PgR (n = 25). Double labeling with antibodies to either ER or PgR coupled with either [3H]thymidine histoautoradiography or with antibodies to the Ki67 proliferation antigen indicates that dividing cells are separate from those expressing the receptors (although they are often in close proximity). However, in contrast to the normal human breast, two-thirds of ER-positive human mammary tumors examined (n = 19) have a high proportion of dividing cells that are ER positive. These data are consistent with the hypothesis that cells in normal human breast epithelium are hierarchical in organization and support a model in which proliferation of ER-negative cells is controlled by paracrine factors released from ER-positive cells under the influence of estradiol. This organization may be disrupted in some tumors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9371488

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  226 in total

Review 1.  Progesterone signaling and mammary gland morphogenesis.

Authors:  G Shyamala
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-01       Impact factor: 2.673

2.  Distinct expression patterns of ER alpha and ER beta in normal human mammary gland.

Authors:  V Speirs; G P Skliris; S E Burdall; P J Carder
Journal:  J Clin Pathol       Date:  2002-05       Impact factor: 3.411

Review 3.  Hormonal control of alveolar development and its implications for breast carcinogenesis.

Authors:  Cathrin Brisken
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-01       Impact factor: 2.673

4.  Estrogen receptors ER alpha and ER beta in proliferation in the rodent mammary gland.

Authors:  Guojun Cheng; Zhang Weihua; Margaret Warner; Jan-Ake Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-04       Impact factor: 11.205

Review 5.  Progesterone receptors in mammary gland development and tumorigenesis.

Authors:  Orla M Conneely; Biserka M Jericevic; John P Lydon
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-04       Impact factor: 2.673

Review 6.  Progesterone regulation of reproductive function through functionally distinct progesterone receptor isoforms.

Authors:  Orla M Conneely; Biserka M Jericevic
Journal:  Rev Endocr Metab Disord       Date:  2002-09       Impact factor: 6.514

Review 7.  Steroid receptors and cell cycle in normal mammary epithelium.

Authors:  Elizabeth Anderson; Robert B Clarke
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673

Review 8.  Hormone action in the mammary gland.

Authors:  Cathrin Brisken; Bert O'Malley
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-08-25       Impact factor: 10.005

9.  Progesterone stimulates proliferation and promotes cytoplasmic localization of the cell cycle inhibitor p27 in steroid receptor positive breast cancers.

Authors:  Anastasia Kariagina; Jianwei Xie; Ingeborg M Langohr; Razvan C Opreanu; Marc D Basson; Sandra Z Haslam
Journal:  Horm Cancer       Date:  2013-08-31       Impact factor: 3.869

10.  Prolactin-growth factor crosstalk reduces mammary estrogen responsiveness despite elevated ERalpha expression.

Authors:  Lisa M Arendt; Tara L Grafwallner-Huseth; Linda A Schuler
Journal:  Am J Pathol       Date:  2009-01-29       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.